Skip to main content
Fig. 5 | BMC Neurology

Fig. 5

From: An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15

Fig. 5

Worldwide distribution of symptomatic patients per genetic subtype. Worldwide estimated distribution of SPG4 (a), SPG11 (b), SPG7 (c), and SPG15 (d) symptomatic patients, divided by UN regions: Sub-Saharan Africa, Northern Africa and Western Asia, Central and Southern Asia, Eastern and South-Eastern Asia, Latin America and The Caribbean, Australia/New Zealand, Oceania (no Australia and New Zealand), Europe, and Northern America

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us